342 related articles for article (PubMed ID: 18393602)
1. Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection.
Leligdowicz A; Rowland-Jones S
Expert Rev Vaccines; 2008 Apr; 7(3):319-31. PubMed ID: 18393602
[TBL] [Abstract][Full Text] [Related]
2. The prospects for vaccines against HIV-1: more than a field of long-term nonprogression?
Sheppard N; Sattentau Q
Expert Rev Mol Med; 2005 Feb; 7(2):1-21. PubMed ID: 15710051
[TBL] [Abstract][Full Text] [Related]
3. [HIV/AIDS vaccines: heading for new vaccine approaches?].
Girard MP
Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
[TBL] [Abstract][Full Text] [Related]
4. Challenges in the development of an effective HIV vaccine: current approaches and future directions.
Klein E; Ho RJ
Clin Ther; 2000 Mar; 22(3):295-314; discussion 265. PubMed ID: 10963285
[TBL] [Abstract][Full Text] [Related]
5. [AIDS vaccines: promises and reality].
Goudsmit J
Ned Tijdschr Geneeskd; 2001 Jun; 145(26):1241-5. PubMed ID: 11455689
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.
Betts MR; Gray CM; Cox JH; Ferrari G
Expert Rev Vaccines; 2006 Aug; 5(4):505-16. PubMed ID: 16989631
[TBL] [Abstract][Full Text] [Related]
7. Notes on the pathogenesis of human immunodeficiency virus infection.
Piconi S; Clerici M
Ann Ist Super Sanita; 1997; 33(2):219-23. PubMed ID: 9470244
[TBL] [Abstract][Full Text] [Related]
8. The natural history, current status, and future trends of HIV infection.
Lears MK; Alwood KS
Lippincotts Prim Care Pract; 2000; 4(1):1-19. PubMed ID: 11022516
[TBL] [Abstract][Full Text] [Related]
9. Environmental factors in HIV/AIDS epidemic development: new perspectives for gender equity and global protection against HIV transmission.
Alfsen A
Ann N Y Acad Sci; 2004 Jun; 1023():164-74. PubMed ID: 15253905
[TBL] [Abstract][Full Text] [Related]
10. A safe, effective and affordable HIV vaccine--an urgent global need.
Joseph J; Etcheverry F; Alcami J; MarĂa GJ
AIDS Rev; 2005; 7(3):131-8. PubMed ID: 16302460
[TBL] [Abstract][Full Text] [Related]
11. Immune impairment thresholds in HIV infection.
Iwami S; Nakaoka S; Takeuchi Y; Miura Y; Miura T
Immunol Lett; 2009 Apr; 123(2):149-54. PubMed ID: 19428563
[TBL] [Abstract][Full Text] [Related]
12. The role of mucosal immunity in development of an acquired immunodeficiency syndrome (AIDS) vaccine: workshop summary.
Muul LM; Glass MJ; Wescott SL; Burkhardt AL; Koff WC; Strober WG
Reg Immunol; 1989; 2(3):188-92. PubMed ID: 2701579
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity against HIV infection: lessons from HIV-2 infection.
Rowland-Jones S
Future Microbiol; 2006 Dec; 1(4):427-33. PubMed ID: 17661633
[TBL] [Abstract][Full Text] [Related]
14. AIDS vaccine: efficacy, safety and ethics.
Veljkovic V; Veljkovic N; Glisic S; Ho MW
Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
[TBL] [Abstract][Full Text] [Related]
15. [The WHO statement on strategies of HIV vaccinations: field trials in developing countries should await studies of the effects].
Lennholm B
Lakartidningen; 1993 Mar; 90(13):1245-6. PubMed ID: 8469070
[TBL] [Abstract][Full Text] [Related]
16. HIV-1/AIDS vaccine development: are we in the darkness.
Qiu C; Xu JQ
Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
[No Abstract] [Full Text] [Related]
17. Immunopathogenesis of human immunodeficiency virus.
Ahsan N; Langhoff E
Semin Nephrol; 1998 Jul; 18(4):422-35. PubMed ID: 9692354
[TBL] [Abstract][Full Text] [Related]
18. Facts concerning the human immunodeficiency virus (HIV) infection and also the acquired immune deficiency syndrome (AIDS).
Persaud V
West Indian Med J; 1993 Dec; 42(4):137. PubMed ID: 8160452
[No Abstract] [Full Text] [Related]
19. Immunology of HIV infection and AIDS: memorandum from a WHO/IUIS meeting.
Bull World Health Organ; 1987; 65(4):453-63. PubMed ID: 3319268
[TBL] [Abstract][Full Text] [Related]
20. [Design, development and successful application of safe and effective HIV therapeutic and prophylactic vaccines].
Abalaka JO
Zhonghua Nan Ke Xue; 2005 Jan; 11(1):8-16. PubMed ID: 15704674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]